Atriva Therapeutics

Atriva Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $113K
Latest Deal Amount
  • Investors
  • 6

Atriva Therapeutics General Information

Description

Developer of antiviral therapies designed to treat different respiratory infections. The company's therapies uses re-purposed and optimized MEK kinase inhibitors to focus on acute viral infections like Influenza, Hanta or respiratory syncytial virus, enabling patients to access efficacious and safe therapeutics against numerous viral infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Christophstraße 32
  • 72072 Tübingen
  • Germany
+49 0701 0000 0000

Atriva Therapeutics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atriva Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 17-Jul-2019 $113K 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 03-Jan-2019 00.000 00.000 Completed Startup
1. Seed Round 21-Sep-2017 $3.58M $3.58M Completed Startup

Atriva Therapeutics Competitors (52)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Aura Biosciences Venture Capital-Backed Cambridge, MA 00 00000 0000000000 0 00000
000000 00000000000 Formerly VC-backed Boston, MA 0000 00.000 0000 00.000
000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
00000 000000000000 Formerly VC-backed New York, NY 00 000.00 000000000000 000.00
00000000 Formerly VC-backed Waltham, MA 00 00000 000000&0 00000

Atriva Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Rainer Lichtenberger Ph.D Co-Founder & Chief Executive Officer
Christian Wallasch Ph.D Chief Operating Officer
Oliver Planz Ph.D Chief Scientific Officer
Henrik Luessen Ph.D Co-Founder & CBO

1 Former Executive

Atriva Therapeutics Board Members (3)

Name Representing Role Since
Frank Hensel Ph.D High-Tech Gründerfonds Board Member 000 0000
Frans Van Dalen Self Board Member 000 0000
Paul Lelieveld Stichting Participatie Atriva Board Member 000 0000

Atriva Therapeutics Investors (6)

To view Atriva Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Integrated Biobank of Luxembourg Government 000 0000 000000 0
B.I.F. Venture Capital Minority 000 0000 000000 0
Meneldor Venture Capital Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
InSynchrony Ventures Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial